Erasca (ERAS) Non-Current Assets (2020 - 2026)

Erasca (ERAS) reported Non-Current Assets of $207.4 million for Q1 2026, up 32.45% on a YoY basis from $156.6 million in Q1 2025, and up 88.74% quarter-over-quarter from $109.9 million in Q4 2025.

Erasca (ERAS) Non-Current Assets (2020 - 2026) Analysis & Trends

Erasca has reported Non-Current Assets for 7 years, with the latest figure at $207.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets rose 32.45% year-over-year to $207.4 million; the trailing twelve-month figure through Mar 2026 stood at $572.6 million (down 12.83% YoY), and the FY2025 full-year result was $109.9 million, down 43.26% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $207.4 million, up from $109.9 million in the prior quarter.
  • The five-year high for Non-Current Assets was $207.4 million in Q1 2026, with the low at $63.4 million in Q1 2024.
  • Historically, Non-Current Assets has averaged $114.9 million across 5 years, with a median of $109.9 million in 2025.
  • Annual changes were most pronounced in 2022 — Non-Current Assets soared 384.28% — and 2025, when it plunged 43.26%.
  • Erasca's Non-Current Assets stood at $70.4 million in 2022, then advanced by 5.98% to $74.6 million in 2023, then soared by 159.62% to $193.7 million in 2024, then sank by 43.26% to $109.9 million in 2025, then jumped by 88.74% to $207.4 million in 2026.
  • The last three Non-Current Assets figures came in at $207.4 million (Q1 2026), $109.9 million (Q4 2025), and $120.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Erasca 4.16 Bn 3.92 Bn - 207.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 207.45 Mn
Dec 31, 2025 109.92 Mn
Sep 30, 2025 120.48 Mn
Jun 30, 2025 134.73 Mn
Mar 31, 2025 156.63 Mn
Dec 31, 2024 193.73 Mn
Sep 30, 2024 198.72 Mn
Jun 30, 2024 107.74 Mn
Mar 31, 2024 63.40 Mn
Dec 31, 2023 74.62 Mn
Sep 30, 2023 113.44 Mn
Jun 30, 2023 116.81 Mn
Mar 31, 2023 69.66 Mn
Dec 31, 2022 70.41 Mn
Sep 30, 2022 80.68 Mn
Jun 30, 2022 63.40 Mn
Mar 31, 2022 72.10 Mn
Dec 31, 2021 81.40 Mn
Sep 30, 2021 29.64 Mn
Jun 30, 2021 13.09 Mn